Phase I Trial of the Safety and Efficacy of Deflexifol for Refractory or Recurrent Paediatric Central Nervous System (CNS) Tumours
ACTRN 12623000104651 Brief Summary This is a multicentre Phase I clinical trial…
Read more arrow_forwardACTRN 12623000104651 Brief Summary This is a multicentre Phase I clinical trial…
Read more arrow_forwardNCT 05544552 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forwardNCT 06819735 Brief Summary This is a phase 1/2, dose-escalation and cohort-expansion…
Read more arrow_forwardNCT 04585750 Brief Summary The Phase 2 monotherapy portion of this study…
Read more arrow_forwardNCT 06003621 Brief Summary This phase II study will explore the effect…
Read more arrow_forwardNCT 05356741 Brief Summary This first-in-human (FIH) Phase 1 open-label multicenter dose-escalation…
Read more arrow_forwardNCT 04589845 Brief Summary TAPISTRY is a Phase II, global, multicenter, open-label,…
Read more arrow_forward